Hereditary persistence of fetal hemoglobin (HPFH) is a genetic condition characterized by the continued production of fetal hemoglobin (HbF) into adulthood. This condition is caused by mutations in the regulatory genes that control hemoglobin production. Clinically, HPFH is significant as it can lead to a mild form of anemia or provide a protective effect against sickle cell disease and beta-thalassemia. The ICD-10 Code D56.4 facilitates accurate diagnosis, documentation, medical billing, and public health reporting for this condition.
ICD-10 Code D56.4 represents Hereditary persistence of fetal hemoglobin (HPFH), a condition where individuals continue to produce fetal hemoglobin beyond the typical perinatal period. This condition is often benign but can be associated with mild anemia. The code should be used in clinical documentation and billing when diagnosing patients with HPFH, ensuring proper identification of the condition for treatment and management.
Hereditary persistence of fetal hemoglobin (HPFH) is primarily caused by genetic mutations that affect the regulation of hemoglobin production, leading to elevated levels of fetal hemoglobin in adults. This condition is generally asymptomatic but may require medical attention if anemia develops. Understanding HPFH is crucial for appropriate management and genetic counseling.
ICD-10 Code D56.4 is utilized in SOAP notes to document the presence of hereditary persistence of fetal hemoglobin (HPFH). It aids in capturing patient symptoms, assessments, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
In SOAP notes, ICD-10 Code D56.4 connects subjective patient reports and objective clinical findings to a formal diagnosis of HPFH. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of hereditary persistence of fetal hemoglobin (HPFH) typically focuses on monitoring and supportive care, as the condition is often asymptomatic. In cases where anemia is present, treatment may be necessary.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D56.4 is crucial for billing purposes, particularly in hospital, emergency room, or outpatient settings where HPFH is diagnosed or managed.
| CPT Code | Description |
|---|---|
| 85025 | Complete blood count (CBC) with differential. |
| 36415 | Collection of venous blood by venipuncture. |
| 81256 | Genetic testing for hemoglobinopathies. |
Common Questions About Using ICD-10 Code D56.4 for Hereditary persistence of fetal hemoglobin [HPFH]
What are the symptoms of hereditary persistence of fetal hemoglobin?
Most individuals with hereditary persistence of fetal hemoglobin (HPFH) are asymptomatic. However, some may experience mild anemia, fatigue, or weakness, particularly if hemoglobin levels drop significantly.
Is hereditary persistence of fetal hemoglobin a serious condition?
HPFH is generally considered a benign condition. While it can lead to mild anemia, it often provides a protective effect against more severe hemoglobin disorders, such as sickle cell disease.
How is hereditary persistence of fetal hemoglobin diagnosed?
Diagnosis of HPFH typically involves blood tests to measure hemoglobin levels and the percentage of fetal hemoglobin. Genetic testing may also be conducted to confirm the diagnosis.
Can hereditary persistence of fetal hemoglobin be treated?
Treatment for HPFH is usually not necessary unless anemia is present. In such cases, supportive care and monitoring are recommended to manage symptoms.
Clinical Notes
SOAP notes
DAP notes
AI medical notes